Physicians’ perceptions of adherence to prophylactic clotting factor infusions
- 20 November 2007
- journal article
- Published by Wiley in Haemophilia
- Vol. 14 (1), 25-29
- https://doi.org/10.1111/j.1365-2516.2007.01591.x
Abstract
The objective of this study was to investigate whether paediatric Haemophilia Treatment Centre (HTC) physicians are concerned about poor adherence to prophylaxis and if such concerns decrease prescription of prophylaxis in patients with haemophilia. Fifty-nine HTC physicians completed a written survey based on self-report of individual practice. Fifty-one (86%) prescribed prophylaxis on a routine basis. Overall, 32 (54%) believed that 76-100% of the patients on prophylaxis infuse > or =80% of the recommended prophylaxis doses and 25 (42%) believed that 51-75% of the patients infuse > or =80% of the doses. Physicians utilize multi-modal methods to make this assessment. Forty-eight (81%) respondents identified that perceptions of patient non-adherence decrease their prescription of prophylaxis. In fact, 30% decided not to prescribe prophylaxis for individual patients within the last year secondary to concerns about non-adherence. Strategies should be developed to improve the implementation of prophylaxis.Keywords
This publication has 17 references indexed in Scilit:
- Adherence to prophylactic infusions of factor VIII or factor IX for haemophiliaHaemophilia, 2006
- Practice patterns in haemophilia A therapy – global progress towards optimal careHaemophilia, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005
- The promise and challenges of bioengineered recombinant clotting factorsJournal of Thrombosis and Haemostasis, 2005
- Why is primary prophylaxis underutilized in the United States?Haemophilia, 2003
- North American prophylaxis studies for persons with severe haemophilia: background, rationale and designHaemophilia, 2003
- Results of secondary prophylaxis in children with severe hemophiliaAmerican Journal of Hematology, 1994
- The Relative Risk of Incident Coronary Heart Disease Associated With Recently Stopping the Use of β-BlockersJAMA, 1990
- Patient compliance and the conduct and interpretation of therapeutic trialsControlled Clinical Trials, 1987
- IMPROVEMENT OF MEDICATION COMPLIANCE IN UNCONTROLLED HYPERTENSIONThe Lancet, 1976